Genzyme Corp U.S. Patent Office approve patent company's method test serum alpha amylase indicator pancreatic disease. "The patent strengthens Genzyme's proprietary position lead independent supplier diagnostic enzyme substrates" Henri Temeer Genzyme president said. The company technology combine unique substrate indicator enzyme diagnostic assay measure serum amylase levels. Genzyme 1985 enter licensing agreement technology amylase test kit makers. Reuter 